199 related articles for article (PubMed ID: 7167246)
1. [Recent findings in drug treatment of liver disease patients with ornithine-carbamyl-transferase (OCT). Personal experience].
Alvisi V; Tralli M; Tampieri ML; Lo Ponte A; D'Ambrosi A
Minerva Dietol Gastroenterol; 1982; 28(4):335-40. PubMed ID: 7167246
[No Abstract] [Full Text] [Related]
2. [Therapeutic use of ornithine-carbamyl-transferase in liver diseases].
Maccá F; Gatta A; Caregaro L; Lauro S; Milani L; Zuin R; Menozzi L
Minerva Dietol Gastroenterol; 1982; 28(1):71-8. PubMed ID: 7078779
[No Abstract] [Full Text] [Related]
3. [Use of ornithine carbamoyltransferase in the treatment of liver diseases].
Caruso N; De Jacobis M; Roccato M; Sequino A; Sgoifo B; Tinello M
Clin Ter; 1984 Jul; 110(1):37-44. PubMed ID: 6237844
[No Abstract] [Full Text] [Related]
4. [Enzymatic therapy in hepatology with ornithine carbamol transferase].
Monges H; Hancy A; Codinach N
Mars Med; 1971; 108(12):881-5. PubMed ID: 5145506
[No Abstract] [Full Text] [Related]
5. [Treatment of hepatocellular insufficiency with ornithine carbamyl transferase].
Heully F; Gaucher P; Jeanpierre R
Therapeutique; 1972; 48(5):381-4. PubMed ID: 5076530
[No Abstract] [Full Text] [Related]
6. [Trofopar treatment of chronic diffuse diseases of the liver].
Loginov AS; Nikolaeva AP; Bendikov EA; Blok IuE; Sukhareva GV
Sov Med; 1989; (7):79-81. PubMed ID: 2799537
[No Abstract] [Full Text] [Related]
7. [Clinico-biological therapeutic effect of intramuscular ornithine-carbamyl-transferase in chronic active hepatitis].
Sanchís Closa A; Caballería Rovira E; Arago López JV; Massó Ubeda RM
Rev Esp Enferm Apar Dig; 1988 Apr; 73(4):351-4. PubMed ID: 3387645
[No Abstract] [Full Text] [Related]
8. [Use of "Essenciale" in the treatment of liver diseases].
Pogromov AP; Ol'binskaia LI; Antonenko NI; Gitel' NP; Smolianitskiĭ AIa
Klin Med (Mosk); 1978 Oct; 56(10):97-101. PubMed ID: 362064
[No Abstract] [Full Text] [Related]
9. [Activity of guanase and ornithine carbamyl transferase in blood serum of patients with liver disease].
Boroń P; Kucharski C; Prokopowicz D; Kossakowski R; Neczyperowicz J
Przegl Lek; 1972; 29(7):675-9. PubMed ID: 5073033
[No Abstract] [Full Text] [Related]
10. [Ornithine carbamyl transferase (S-OCT)--interpretation of the test results].
Takeda H; Kamano T; Kamiyama Y; Honko I
Nihon Rinsho; 1973; 31():1794-801. PubMed ID: 4795308
[No Abstract] [Full Text] [Related]
11. [Evaluation of hepatic lesions in hyperthyroid conditions by means of determination of serum ornithine-carbamyl-transferase].
Bonera E; Bertoni P
Quad Sclavo Diagn; 1974 Dec; 10(4):509-14. PubMed ID: 4156600
[TBL] [Abstract][Full Text] [Related]
12. [The valve of the determination of the ornithine-carbamyl transferase in the serum and its comparison with the determination of the glutamo-pyruvic transaminase in clinical hepatology].
Cachin M; Girard ML; Charbonnier A; Rousselet F; Koch M; Khoury K
Pathol Biol; 1965 May; 13(9):477-88. PubMed ID: 5320274
[No Abstract] [Full Text] [Related]
13. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
Reutter FW; Haase W
Schweiz Rundsch Med Prax; 1975 Sep; 64(36):1145-51. PubMed ID: 1099576
[No Abstract] [Full Text] [Related]
14. [Value of the determination of serum ornithine-carbamoyl transferase and of sulfobromophthalein clearance in the laboratory diagnosis of chronic liver diseases].
Ceriotti G; Zotti S; Bonini PA
Quad Sclavo Diagn; 1971 Dec; 7(4):1192-212. PubMed ID: 5161741
[No Abstract] [Full Text] [Related]
15. [Experiences with ornithine-aspartate in liver diseases].
Aschke J
Med Welt; 1969 Mar; 12():657-62. PubMed ID: 5767441
[No Abstract] [Full Text] [Related]
16. [The anti-steatosic effect of sulfo-adenosylmethionine (SAMe) in various forms of chronic hepatopathy. Multicentric research].
Mazzanti R; Arcangeli A; Salvadori G; Smorlesi C; Di Perri T; Auteri A; Boggiano CA; Pippi L; Toti M; Boncompagni P; Angioli D; Caremani M; Magnolfi F; Camarri E; Motta R; Forconi A; Candidi Tommasi A; Lomi M; Soldi A
Minerva Med; 1978 Oct; 69(48):3283-92. PubMed ID: 724140
[No Abstract] [Full Text] [Related]
17. [Further clinical experiences with ornithine aspartate in liver diseases].
Wotzka R; Weber D
Ther Ggw; 1972 Mar; 111(3):400-12. PubMed ID: 5024593
[No Abstract] [Full Text] [Related]
18. [Our experience with long-term therapy of chronic liver diseases using Superanabolon Spofa].
Svacinka P; Horký J; Blahníková L
Vnitr Lek; 1970 Dec; 16(12):1181-7. PubMed ID: 5491517
[No Abstract] [Full Text] [Related]
19. [Hepason in the treatment of hepatocellular diseases].
Stazka Z; Korolko A
Pol Tyg Lek; 1970 Jul; 25(28):1062-4. PubMed ID: 5451158
[No Abstract] [Full Text] [Related]
20. [A new multienzyme complex. Clinical trial in hepatitis and cirrhosis].
Ribet A; Vidal JL
Nouv Presse Med; 1972 Nov; 1(42):2843-4. PubMed ID: 4663747
[No Abstract] [Full Text] [Related]
[Next] [New Search]
